comparemela.com

Latest Breaking News On - Department of gynecology - Page 1 : comparemela.com

Dr Modesitt on Shared Decision-Making When Choosing PARP Inhibitors in Ovarian Cancer

Susan C. Modesitt, MD, FACOG, FACS, discusses the role of PARP inhibitors in the treatment of patients with ovarian cancer.

Susanc modesittDivision of gynecologic oncologyEmory university school of medicineDepartment of gynecologyGynecologic oncologyEmory university school

Dr Meisel on Perceptions of Patient/Provider Communication in Breast Cancer Care

Jane L. Meisel, MD, shares information from a study that evaluated patient-reported perceptions of patient-provider communication in breast cancer care.

Janel meiselEmory university school of medicineDepartment of hematologyDepartment of gynecologyMedical oncologyEmory university school

Dr Meisel on Patient-Reported Perceptions of Provider Communication in Breast Cancer Care

Jane L. Meisel, MD, discusses patient-reported perceptions of patient-provider communication in cancer care.

Janel meiselDepartment of gynecologyEmory university school of medicineDepartment of hematologyMedical oncologyEmory university schoolWinship cancer institute of emory universityOnclive tvBreast cancer

Patient Toxicity and QOL Concerns Must Be Considered in Breast Cancer Treatment Decision-Making

Jane L. Meisel, MD, discusses the importance of prioritizing patients’ toxicity concerns and quality of life in the management of breast cancer.

United statesEmory university school of medicineSan antonioJanel meiselDepartment of gynecologyQuality of lifeDepartment of hematologyLife surveyAntonio breast cancer symposiumMedical oncologyEmory university schoolEstrogen receptor positive her2 negativeBreast cancerTreatment related adverse effectsHealthcare providersTolerability concerns

Addressing Patient-Provider Communication Challenges is Vital for Improved Breast Cancer Care

Jane L. Meisel, MD, highlighted patient-reported gaps in provider communication regarding treatment-related toxicities in metastatic breast cancer.

United statesEmory university school of medicineJanel meiselDepartment of gynecologyDepartment of hematologyQuality of lifeLife surveyAntonio breast cancer symposiumMedical oncologyEmory university schoolEstrogen receptor positive her2 negativeBreast cancerTreatment related adverse effectsHealthcare providersTolerability concernsShared decision making

vimarsana © 2020. All Rights Reserved.